Eurofins Scientific SE (ERF.PA)
EUR 47.59
(0.38%)
EUR 47.59
(0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 947.3 Million | 1.13 Billion | 1.5 Billion | 1.22 Billion | 677.9 Million | 543.89 Million |
| Net Income | 310.3 Million | 780 Million | 1.05 Billion | 694.4 Million | 271.5 Million | 289.84 Million |
| Depreciation & Amortization | 664.3 Million | 504.4 Million | 450.7 Million | 426 Million | 395.9 Million | 223.74 Million |
| Deferred income taxes | -1.51 Billion | - | -298.9 Million | -95.8 Million | -95.6 Million | -68.2 Million |
| Stock-based compensation | 137.7 Million | 136.1 Million | 131 Million | 124.5 Million | 70.5 Million | 83.7 Million |
| Change in working capital | -64.8 Million | 33 Million | -6.6 Million | -29.7 Million | -56.8 Million | -21.44 Million |
| Other non-cash items | 1.41 Billion | -317.2 Million | 176.9 Million | 104.1 Million | 92.4 Million | 36.22 Million |
| Investing Cash Flow | -692.7 Million | -855.9 Million | -1.03 Billion | -525 Million | -540.2 Million | -1.55 Billion |
| Investments in PPE | -550.1 Million | -660.2 Million | -519.5 Million | -355.5 Million | -425.1 Million | -364.44 Million |
| Acquisitions | -144.4 Million | -214.7 Million | -532.7 Million | -177.2 Million | -171 Million | -1.25 Billion |
| Investment purchases | - | -1.5 Million | -8.4 Million | -100 Thousand | -47.6 Million | - |
| Sales/Maturities of investments | 1.9 Million | 1.5 Million | 8.4 Million | 100 Thousand | 47.6 Million | 53.87 Million |
| Other Investing Activities | -100 Thousand | 19 Million | 18 Million | 7.7 Million | 55.9 Million | 61.25 Million |
| Financing Cash Flow | 495.8 Million | -311.3 Million | -910.3 Million | -48.6 Million | -342.2 Million | 691.06 Million |
| Debt repayment | -548.5 Million | -82.9 Million | -453.6 Million | -1.3 Billion | -445 Million | -366.98 Million |
| Dividends payments | -191.9 Million | -192.1 Million | -129.69 Million | -300 Thousand | -51.2 Million | -42.6 Million |
| Common Stock Repurchased | -55.8 Million | -15.8 Million | -3.6 Million | 727.8 Million | -300 Million | 1.12 Billion |
| Common Stock Issuance | 601.5 Million | 14.6 Million | 35.8 Million | 564.8 Million | 321 Million | 20.04 Million |
| Other Financing Activities | 690.5 Million | -34.7 Million | -358.5 Million | -36.2 Million | 133.2 Million | -48.72 Million |
| Accounts receivables | -20 Million | -9 Million | -109.6 Million | 131.5 Million | -145.7 Million | -166.96 Million |
| Accounts payables | -41.4 Million | 20.1 Million | 85.6 Million | 132.19 Million | 36.8 Million | 71.14 Million |
| Inventory | 11 Million | 8.6 Million | 2.8 Million | -77.7 Million | -12.9 Million | -14.56 Million |
| Other working capital | -14.4 Million | 13.3 Million | 14.6 Million | -215.69 Million | 65 Million | -6.87 Million |
| Cash at beginning of period | 432.2 Million | 515 Million | 910.5 Million | 294.5 Million | 495 Million | 816.02 Million |
| Cash at end of period | 749.1 Million | 483.2 Million | 515 Million | 910.5 Million | 294.5 Million | 495 Million |
| Capital Expenditure | -550.1 Million | -660.2 Million | -519.5 Million | -355.5 Million | -425.1 Million | -364.44 Million |
| Effect of forex changes on cash | -12.7 Million | -800 Thousand | 39.1 Million | -33.9 Million | 4.1 Million | 1.46 Million |
| Net cash flow / Change in cash | 316.9 Million | -31.8 Million | -395.5 Million | 616 Million | -200.5 Million | -321.02 Million |
| Free Cash Flow | 397.2 Million | 476.1 Million | 990.3 Million | 868 Million | 252.8 Million | 179.44 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 110.35 Million | 110.35 Million | 158.8 Million | 310.3 Million | 79.35 Million | 151.5 Million |
| Depreciation & Amortization | 164.6 Million | 164.6 Million | 353.6 Million | 664.3 Million | 155.3 Million | 310.7 Million |
| Deferred income taxes | - | - | -738.4 Million | -1.51 Billion | - | -651.5 Million |
| Stock-based compensation | 28.8 Million | 28.8 Million | 31.2 Million | 137.7 Million | 31.2 Million | 30.1 Million |
| Change in working capital | -38.85 Million | -38.85 Million | 89.5 Million | -64.8 Million | 60.3 Million | -154.3 Million |
| Other non-cash items | 249.99 Thousand | 249.99 Thousand | 732.7 Million | 1.41 Billion | 16.25 Million | 633.4 Million |
| Investing Cash Flow | -241.95 Million | -241.95 Million | -358.6 Million | -692.7 Million | -176.25 Million | -334.1 Million |
| Investments in PPE | -108.75 Million | -108.75 Million | -287.4 Million | -550.1 Million | -125.05 Million | -262.7 Million |
| Acquisitions | -123.25 Million | -123.25 Million | -73.1 Million | -144.4 Million | -37.35 Million | -71.3 Million |
| Investment purchases | -1.2 Million | - | 100 Thousand | - | - | -100 Thousand |
| Sales/Maturities of investments | - | - | 1.9 Million | 1.9 Million | - | 50.3 Million |
| Other Investing Activities | -9.95 Million | -9.95 Million | -100 Thousand | -100 Thousand | -13.85 Million | -8.6 Million |
| Financing Cash Flow | -294.05 Million | -294.05 Million | 272.2 Million | 495.8 Million | 104.35 Million | 223.6 Million |
| Debt repayment | -433.5 Million | - | -612.8 Million | -548.5 Million | - | -64.3 Million |
| Dividends payments | -1 Million | - | -191.9 Million | -191.9 Million | -112.5 Million | -4.45 Million |
| Common Stock Repurchased | -14.8 Million | -14.8 Million | -19 Million | -55.8 Million | -9.7 Million | -36.8 Million |
| Common Stock Issuance | - | - | -400 Thousand | 601.5 Million | - | 601.9 Million |
| Other Financing Activities | -279.25 Million | -279.25 Million | -33.7 Million | 690.5 Million | 226.55 Million | -192.3 Million |
| Accounts receivables | - | - | -21.7 Million | -20 Million | -21.7 Million | - |
| Accounts payables | - | - | 29.2 Million | -41.4 Million | - | - |
| Inventory | - | - | 5.5 Million | 11 Million | 5.5 Million | - |
| Other working capital | -38.85 Million | -38.85 Million | 76.5 Million | -14.4 Million | 76.5 Million | -77.15 Million |
| Cash at beginning of period | 749.1 Million | - | 686.4 Million | 432.2 Million | 681.6 Million | 432.2 Million |
| Cash at end of period | 623.5 Million | -270.25 Million | 749.1 Million | 749.1 Million | 269.7 Million | 686.4 Million |
| Capital Expenditure | -108.75 Million | -108.75 Million | -287.4 Million | -550.1 Million | -125.05 Million | -262.7 Million |
| Effect of forex changes on cash | 600 Thousand | 600 Thousand | -800 Thousand | -12.7 Million | -800 Thousand | -5.55 Million |
| Net cash flow / Change in cash | -125.6 Million | -270.25 Million | 62.7 Million | 316.9 Million | -411.9 Million | 254.2 Million |
| Free Cash Flow | 156.39 Million | 156.39 Million | 340 Million | 397.2 Million | 217.35 Million | 57.2 Million |
PAISALO
EDELWEISS
EUUNF
TYRES
INDRAMEDCO
HOKCY